These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36012968)

  • 1. Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab.
    Ramón A; Zaragozá M; Torres AM; Cascón J; Blasco P; Milara J; Mateo J
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
    Meleveedu KS; Miskovsky J; Meharg J; Abdelrahman A; Tandon R; Moody AE; Dasilva P; Masse G; LaPorte J; Saied Calvino A; Allen G; El-Bizri R; Roberts T; Armenio V; Katz SC
    Cytokine X; 2020 Dec; 2(4):100035. PubMed ID: 32895645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.
    Lakatos B; Szabo BG; Bobek I; Gopcsa L; Beko G; Kiss-Dala N; Petrik B; Gaspar Z; Farkas BF; Sinko J; Remenyi P; Szlavik J; Valyi-Nagy I
    Acta Microbiol Immunol Hung; 2021 Aug; ():. PubMed ID: 34370690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.
    Antwi-Amoabeng D; Kanji Z; Ford B; Beutler BD; Riddle MS; Siddiqui F
    J Med Virol; 2020 Nov; 92(11):2516-2522. PubMed ID: 32436994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.
    Poggiali E; Zaino D; Immovilli P; Rovero L; Losi G; Dacrema A; Nuccetelli M; Vadacca GB; Guidetti D; Vercelli A; Magnacavallo A; Bernardini S; Terracciano C
    Clin Chim Acta; 2020 Oct; 509():135-138. PubMed ID: 32531257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.
    Price CC; Altice FL; Shyr Y; Koff A; Pischel L; Goshua G; Azar MM; Mcmanus D; Chen SC; Gleeson SE; Britto CJ; Azmy V; Kaman K; Gaston DC; Davis M; Burrello T; Harris Z; Villanueva MS; Aoun-Barakat L; Kang I; Seropian S; Chupp G; Bucala R; Kaminski N; Lee AI; LoRusso PM; Topal JE; Dela Cruz C; Malinis M
    Chest; 2020 Oct; 158(4):1397-1408. PubMed ID: 32553536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19.
    Skarbinski J; Liu L; Hong V; Amsden LB; Fireman BH; Yau VM; Incerti D; Qian L; Fischer H; Ackerson BK; Shaw SF; Tartof SY
    BMJ Open; 2022 Oct; 12(10):e060358. PubMed ID: 36316080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia.
    Valenzuela O; Ibáñez S; Poli MC; Roessler P; Aylwin M; Roizen G; Iruretagoyena M; Agar V; Donoso J; Fierro M; Montes J
    Front Med (Lausanne); 2020; 7():596916. PubMed ID: 33304913
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia.
    Capra R; De Rossi N; Mattioli F; Romanelli G; Scarpazza C; Sormani MP; Cossi S
    Eur J Intern Med; 2020 Jun; 76():31-35. PubMed ID: 32405160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
    Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
    Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.
    Gokhale Y; Mehta R; Kulkarni U; Karnik N; Gokhale S; Sundar U; Chavan S; Kor A; Thakur S; Trivedi T; Kumar N; Baveja S; Wadal A; Kolte S; Deolankar A; Pednekar S; Kalekar L; Padiyar R; Londhe C; Darole P; Pol S; Gokhe SB; Padwal N; Pandey D; Yadav D; Joshi A; Badgujar H; Trivedi M; Shah P; Bhavsar P
    BMC Infect Dis; 2021 Mar; 21(1):241. PubMed ID: 33673818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Mortality in Tocilizumab-Treated Severe COVID-19.
    Pagkratis K; Chrysikos S; Antonakis E; Pandi A; Kosti CN; Markatis E; Hillas G; Digalaki A; Koukidou S; Chaini E; Afthinos A; Dimakou K; Papanikolaou IC
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
    Jordan SC; Zakowski P; Tran HP; Smith EA; Gaultier C; Marks G; Zabner R; Lowenstein H; Oft J; Bluen B; Le C; Shane R; Ammerman N; Vo A; Chen P; Kumar S; Toyoda M; Ge S; Huang E
    Clin Infect Dis; 2020 Dec; 71(12):3168-3173. PubMed ID: 32575124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence in clinical care amidst COVID-19 pandemic: A systematic review.
    Adamidi ES; Mitsis K; Nikita KS
    Comput Struct Biotechnol J; 2021; 19():2833-2850. PubMed ID: 34025952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.